Skip to content

Clinical trials

Phase 2 Hidradenitis Suppurativa trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hidradenitis Suppurativa Phase: Phase 2 Country / region: Canada Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20192
20202
20215
20224
20233
20242
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Active, not recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Sanofi4
AbbVie3
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Pfizer2
ACELYRIN Inc.1
Aristea Therapeutics, Inc.1
Avalo Therapeutics, Inc.1
Citryll BV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hidradenitis Suppurativa30
Skin Diseases5
Hidradenitis3
Skin Diseases, Bacterial2
Sweat Gland Diseases2
Acne Vulgaris1
Dermatitis1
Folliculitis1
Inflammation1
Suppuration1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.